Up to $1.4m in Qld Grant for COVID-19 test development

Brisbane based AnteoTech Ltd (ASX: ADO) (“AnteoTech” or “the Company”) is pleased to announce that it has been awarded up to $1.4 million towards the further development and commercialisation of its COVID-19 Antigen Rapid Test (ART)1, under the Queensland Government’s Essential Goods and Supply Chain Program (EGSCP). AnteoTech will draw down up to $1.4 million against agreed milestones. The EGSCP